Arcturus Therapeutics Holdings Inc. (ARCT) Fundamentals

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.
SHARE INFORMATION
Market Cap$ 506,013,798
Shares Outstanding26,492,869
Float17,108,908
Percent Float64.58%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 12,359,000
Latest Fiscal EPS$ -7.74
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions317
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months1,221,264
Institutional Holdings Percent178.0%
Institutional Sold Previous 3 Months2,485,299
Insider Holdings Date2022-11-30
Insider Bought Previous 3 Months5,000
Insider Holdings Percent9.2
Insider Sold Previous 3 Months-
Insider Shares Owned2,427,908
TRADING INFO
52 Week High$ 48.75
52 Week Low$ 11.70
52 Week High Change$ -49.36
21 Day Moving Average$ 18.711
21 Day Extended Moving Average$ 17.8143
50 Day Moving Average$ 16.955
50 Day Extended Moving Average$ 17.4181
200 Day Moving Average$ 18.7152
200 Day Extended Moving Average$ 20.5622
10 Day Average Volume384,673
20 Day Average Volume598,179
30 Day Average Volume691,710
50 Day Average Volume576,681
Alpha0.029168
Beta2.5122
Standard Deviation0.316860
R20.177991
7 Day Price Change$ 2.62
7 Day Percent Change15.9%
21 Day Price Change$ 0.55
21 Day Percent Change2.97%
30 Day Price Change$ -2.59
30 Day Percent Change-11.94%
Month to Date Price Change$ 0.66
Month to Date Percent Change3.58%
Quarter to Date Price Change$ 4.28
Quarter to Date Percent Change28.88%
180 Day Price Change$ 0.30
180 Day Percent Change1.6%
200 Day Price Change$ 2.26
200 Day Percent Change13.42%
Year to Date Price Change$ -17.91
Year to Date Percent Change-48.39%

Arcturus Therapeutics Holdings Inc. (ARCT) Key Ratios

PROFITABILITY
EBIT Margin-279.1%
EBITDA Margin-276.6%
Pre-Tax Profit Margin-354.2%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 51,500,000
Revenue Per Share$ 1.9439
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.50
Total Debt To Equity0.70
Int Coverage-49.20
Current Ratio3.30
Leverage Ratio1.90
Quick Ratio3.20
Long Term Debt To Capital0.30
VALUATION MEASURES
PE Ratio-3.40
Enterprise Value$ 363,078,797
Price to Sales9.8255
Price to Free Cash-2.90
PE High Last 5 Years-2.80
Price To Book3.50
Price To Cash Flow0.00
PE Low Last 5 Years-7.10
Price to Tangible Book3.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover9.90
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-40.28
Return on Equity-72.46
Return on Capital-51.06

Arcturus Therapeutics Holdings Inc. (ARCT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOJoseph E. Payne
Emplyoees177
Last AuditUQ
CIK0001768224
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address10628 Science Center Drive
Suite 250
San Diego, CA 92121
Websitehttps://www.arcturusrx.com
Facsimile-
Telephone+1 858 900-2660
EmailIR@ArcturusRx.com
Your Recent History
NASDAQ
ARCT
Arcturus T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221205 13:58:38